Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM185PE
TNBC
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7532.091
uM
13.00210
19.9110
-0.9881 -0.9968 2.5729 0.5005
0.9982
0.9414
SUM185PE
TNBC
Luminal
Ispinesib
KSP
Kinesin
7532.067
uM
0.09840
0.67187
-0.9893 -1.0000 0.5719 0.6496
0.9465
0.9744
SUM185PE
TNBC
Luminal
Ixabepilone
TUBB
TUBB
7532.095
uM
0.00315
0.10647
-0.9979 -1.0000 0.3122 0.9528
0.8310
0.7413
SUM185PE
TNBC
Luminal
JNK-IN-5A
JNK
JNK
12269.144
uM
inf
inf
-0.2421 -0.2421 0.0000 0.2687
0.5217
1.0241
SUM185PE
TNBC
Luminal
Lapatinib
EGFR/HER2
ErbB
7532.098
uM
inf
inf
0.8747 0.8747 0.0000 0.1305
0.3737
0.6992
SUM185PE
TNBC
Luminal
LBH589
HDAC
HDAC
12269.154
uM
0.07923
0.19201
-0.9328 -0.9155 1.1756 0.7622
0.9993
0.9999
SUM185PE
TNBC
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12269.154
uM
0.04492
0.47511
-0.9659 -1.0000 0.4658 0.7628
0.7945
0.9999
SUM185PE
TNBC
Luminal
Mebendazole
13140.174
uM
0.40247
0.41642
-0.0809 -0.0374 2.1152 0.4704
0.9571
0.5769
SUM185PE
TNBC
Luminal
Methotrexate
DHFR
Metabolism
7532.084
uM
inf
inf
0.8047 0.8047 0.0000 0.0855
0.1512
0.7770
SUM185PE
TNBC
Luminal
Methylglyoxal
13619.184
uM
665.77460
699.53910
-0.6332 -0.1403 5.0000 0.4759
0.5806
0.8825
SUM185PE
TNBC
Luminal
MG-132
Proteasome
Proteasome
12269.145
uM
0.06331
0.08807
-0.9924 -0.8782 3.0716 0.9437
0.9880
0.4894
SUM185PE
TNBC
Luminal
MG-132
Proteasome
Proteasome
12269.145
uM
0.06331
0.08807
-0.9924 -0.8782 3.0716 0.9437
0.9880
0.4894
SUM185PE
TNBC
Luminal
Pevonedistat
NAE1
NAE1
12269.135
uM
0.03219
1.2480
-0.4560 -0.8365 0.2688 0.6831
0.7744
1.0530
SUM185PE
TNBC
Luminal
Nelfinavir
13140.174
uM
5.14150
9.05190
-0.8796 -1.0000 1.9423 0.2983
0.9624
0.5769
SUM185PE
TNBC
Luminal
Nilotinib
ABL
nRTK
12269.145
uM
inf
inf
-0.2047 -0.2047 0.0000 0.3187
0.1533
0.4894
SUM185PE
TNBC
Luminal
NSC 663284
CDC25
CDC
12269.152
uM
0.28492
0.80724
-0.9909 -1.0000 1.0549 0.8215
0.9829
0.8791
SUM185PE
TNBC
Luminal
NU6102
CDK1/2
CDK
12269.147
uM
inf
inf
-0.7298 -0.7298 0.0000 0.5320
0.2531
0.8519
SUM185PE
TNBC
Luminal
Nutlin 3a
MDM2
MDM2
7532.066
uM
24.1910
48.19870
-0.2640 -1.0000 1.5937 0.1621
0.9184
0.9011
SUM185PE
TNBC
Luminal
Olomoucine II
CDK1
CDK
12269.147
uM
0.95156
11.57380
-0.5955 -1.0000 0.4397 0.4958
0.6152
0.8519
SUM185PE
TNBC
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
10146.12
uM
38.30250
59.44580
-0.9703 -0.9779 2.4656 0.3989
0.9889
1.0341
SUM185PE
TNBC
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
7921.011
uM
33.13270
44.30690
-0.9812 -0.9843 3.7441 0.4150
0.9918
0.6757
SUM185PE
TNBC
Luminal
Oxamflatin
HDAC
HDAC
12269.147
uM
0.31755
1.27050
-0.9871 -1.0000 0.7924 0.6283
0.9894
0.8519
SUM185PE
TNBC
Luminal
PD 98059
MEK
MAPK
12269.152
uM
inf
inf
0.1019 0.1019 0.0000 0.1402
0.2810
0.8791
SUM185PE
TNBC
Luminal
PD184352
MEK
MAPK
12269.155
uM
inf
inf
0.4424 0.4424 0.0000 0.3571
0.2001
0.7969
SUM185PE
TNBC
Luminal
PD184352
MEK
MAPK
12269.155
uM
inf
inf
0.4424 0.4424 0.0000 0.3571
0.2001
0.7969